Isolated viral protein TNF antagonists
US5464938A · kind A · utility
31Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 1994 |
| Grant date | Nov 7, 1995 |
| Priority date | — |
| Expiry date | Aug 18, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/24022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Isolated viral proteins, and pharmaceutical compositions made therefrom, are disclosed which are capable of binding to cytokines, thereby functioning as cytokine antagonists. Also disclosed are processes for preparing isolated vital protein cytokine antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.